Works matching IS 0008543X AND DT 2017 AND VI 123 AND IP 23


Results: 28
    1
    2
    3
    4
    5
    6

    Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).

    Published in:
    2017
    By:
    • Bhatia, Aarti K.;
    • Lee, Ju‐Whei;
    • Pinto, Harlan A.;
    • Jacobs, Charlotte D.;
    • Limburg, Paul J.;
    • Rubin, Philip;
    • Arusell, Robert M.;
    • Dunphy, Eamonn P.;
    • Khandekar, Janardan D.;
    • Reiner, Seth A.;
    • Baez‐Diaz, Luis;
    • Celano, Paul;
    • Li, Shuli;
    • Li, Yi;
    • Burtness, Barbara A.;
    • Adams, George L.;
    • Pandya, Kishan J.;
    • Lee, Ju-Whei;
    • Baez-Diaz, Luis
    Publication type:
    journal article
    7
    8
    9
    10
    11
    12
    13
    14

    A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.

    Published in:
    2017
    By:
    • Lowery, Maeve A.;
    • Yu, Kenneth H.;
    • Kelsen, David Paul;
    • Harding, James J.;
    • Bomalaski, John S.;
    • Glassman, Danielle C.;
    • Covington, Christina M.;
    • Brenner, Robin;
    • Hollywood, Ellen;
    • Barba, Adalberto;
    • Johnston, Amanda;
    • Liu, Kay Chia‐Wei;
    • Feng, Xiaoxing;
    • Capanu, Marinela;
    • Abou‐Alfa, Ghassan K.;
    • O'Reilly, Eileen M.;
    • Liu, Kay Chia-Wei;
    • Abou-Alfa, Ghassan K
    Publication type:
    journal article
    15
    16
    17
    18
    19
    20
    22
    23

    Issue Information - TOC.

    Published in:
    Cancer (0008543X), 2017, v. 123, n. 23, p. 4515, doi. 10.1002/cncr.30310
    Publication type:
    Article
    24
    25
    26
    27
    28